Evidence map›Paper›PMID 21860239›Full record

ArticleCaries research2011

Clinical efficacy of a specifically targeted antimicrobial peptide mouth rinse: targeted elimination of Streptococcus mutans and prevention of demineralization.

R Sullivan, P Santarpia, S Lavender, E Gittins, Z Liu, M H Anderson, J He, W Shi, R Eckert

Open access · bronzeAbstract read
In one paragraph

Article in Caries research, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed, 1 pooled it
3.7field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 1 synthesis or guideline pooled it, 85 citations in OpenAlex.

  1. Peptide Designs for Use in Caries Management: A Systematic Review.International journal of molecular sciences · 2023
    Pooled it
  2. Trial
  3. Article
  4. Review
  5. Therapeutic Bioactivity Exerted by theMolecules (Basel, Switzerland) · 2025
    Article
  6. Engineered Tissue Models to Decode Host-Microbiota Interactions.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Designed Multifunctional Peptides for Intracellular Targets.Antibiotics (Basel, Switzerland) · 2022
    Review
  13. [Materials for Selective Inhibition ofSichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition · 2022
    Review
  14. Review
  15. Frontiers in dentistry · 2022
    Review
  16. Novel antimicrobial agents targeting theFrontiers in cellular and infection microbiology · 2022
    Review
  17. Review
  18. Article
  19. [Effects of antimicrobial peptide GH12 on the morphology and composition of cariogenic three-species biofilm].Hua xi kou qiang yi xue za zhi = Huaxi kouqiang yixue zazhi = West China journal of stomatology · 2021
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

R SullivanColgate-Palmolive Technology Center, Piscataway, NJ, USA.
P Santarpia
S Lavender
E Gittins
Z Liu
M H Anderson
J He
W Shi
R Eckert
Colgate-Palmolive (United States) · USC3J Therapeutics (United States) · USUniversity of California, Los Angeles · US

Funding

Making a quantum leap in plaque research with modern sciencesR01DE020102 · NIDCR · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI HE, XUESONG, MCLEAN, JEFFREY SCOTT · 2010 to 2020
$3.7M
Targeted antimicrobial therapy for dental cariesR42MD001831 · NIMHD · C3 JIAN, LLC · PI ANDERSON, MAXWELL H, SHI, WENYUAN · 2007 to 2008
$1.0M
Targeted Antimicrobial Therapy for Dental CariesR41MD001831 · NIMHD · C3 JIAN, INC. · PI ANDERSON, MAXWELL H · 2005 to 2005
$100k
NIDCR NIH HHS DE20102NIDCR NIH HHS R01 DE020102NIMHD NIH HHS MD01831NIMHD NIH HHS R41 MD001831NIMHD NIH HHS R42 MD001831
6 · The paper itself

Abstract

BACKGROUND/

aimsStreptococcus mutans, the major etiological agent of dental caries, has a measurable impact on domestic and global health care costs. Though persistent in the oral cavity despite conventional oral hygiene, S. mutans can be excluded from intact oral biofilms through competitive exclusion by other microorganisms. This suggests that therapies capable of selectively eliminating S. mutans while limiting the damage to the normal oral flora might be effective long-term interventions to fight cariogenesis. To meet this challenge, we designed C16G2, a novel synthetic specifically targeted antimicrobial peptide with specificity for S. mutans. C16G2 consists of a S. mutans-selective 'targeting region' comprised of a fragment from S. mutans competence stimulation peptide (CSP) conjoined to a 'killing region' consisting of a broad-spectrum antimicrobial peptide (G2). In vitro studies have indicated that C16G2 has robust efficacy and selectivity for S. mutans, and not other oral bacteria, and affects targeted bacteria within seconds of contact.

methodsIn the present study, we evaluated C16G2 for clinical utility in vitro, followed by a pilot efficacy study to examine the impact of a 0.04% (w/v) C16G2 rinse in an intra-oral remineralization/demineralization model. RESULTS AND

conclusionsC16G2 rinse usage was associated with reductions in plaque and salivary S. mutans, lactic acid production, and enamel demineralization. The impact on total plaque bacteria was minimal. These results suggest that C16G2 is effective against S. mutans in vivo and should be evaluated further in the clinic.

Indexed as

AdolescentAdultAgedAnimalsAnti-Infective AgentsAntimicrobial Cationic PeptidesBacterial ProteinsBiofilmsCattleCell Culture TechniquesCell SurvivalDental PlaqueGingivaHemolysisHumansHydrogen-Ion ConcentrationAnti-Infective AgentsAntimicrobial Cationic PeptidesBacterial Proteinscompetence factor, StreptococcusLactic AcidMelittenMouthwashesSucrose

Identifiers

PMID21860239
PMCPMC3169368
OpenAlexW2085565963

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.